The report in Shanghai revealed that breast cancer patients with the GSTP1 105Val allele had a 60% reduction in mortality risk after chemotherapy (HR = 0.4, 95% CI: 0.2-0.8) [30]. The gene discussed is GSTP1; the disease is breast carcinoma.